SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599901-23-000030
Filing Date
2023-05-09
Accepted
2023-05-09 16:13:30
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rna-20230331.htm   iXBRL 10-Q 830369
2 EX-10.1 avidity-nonxemployeedirect.htm EX-10.1 27314
3 EX-31.1 rna-20230331xexx311.htm EX-31.1 9728
4 EX-31.2 rna-20230331xex312.htm EX-31.2 9731
5 EX-32.1 rna-20230331xex321.htm EX-32.1 4953
6 EX-32.2 rna-20230331xex322.htm EX-32.2 4945
  Complete submission text file 0001599901-23-000030.txt   4295553

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20230331.xsd EX-101.SCH 27502
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rna-20230331_cal.xml EX-101.CAL 46706
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rna-20230331_def.xml EX-101.DEF 121612
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20230331_lab.xml EX-101.LAB 403823
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20230331_pre.xml EX-101.PRE 248398
51 EXTRACTED XBRL INSTANCE DOCUMENT rna-20230331_htm.xml XML 673299
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39321 | Film No.: 23902156
SIC: 2834 Pharmaceutical Preparations